Expertise in
51
conditions

Dr. Samith Kochuparambil

Internal Medicine
Office
910 E 26th St Ste 100, 
Minneapolis, MN 
Offers Telehealth
Expertise in
51
conditions
Office
910 E 26th St Ste 100, 
Minneapolis, MN 

Overview

Samith Kochuparambil is an Internal Medicine provider practicing medicine in Minneapolis, Minnesota.

Dr. Kochuparambil is highly rated in 51 conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Neuroendocrine Tumor, Non-Muscle Invasive Bladder Cancer, Muscle Invasive Bladder Cancer, and Bone Marrow Aspiration.

He is actively involved in clinical research, co-authoring 12 peer reviewed articles and participating in 6 clinical trials.

Specialties

Internal Medicine

Licenses

Internal Medicine in MN

Hospital Affiliations

M Health Fairview Southdale Hospital
Abbott Northwestern Hospital

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
HealthPartners
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Metropolitan Health Plan
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
Northern Plains Alliance
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE PDP
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 11 Less Insurance Carriers -

Locations

Office
910 E 26th St Ste 100, Minneapolis, MN 55404
Other Locations
Minnesota Oncology Hematology PA
10150 Niagara Ln N # 100, Maple Grove, MN 55369

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

An Open-Label, Multicenter Follow-up Study to Collect Long-term Data on Participants From Multiple Avelumab (MSB0010718C) Clinical Studies
An Open-Label, Multicenter Follow-up Study to Collect Long-term Data on Participants From Multiple Avelumab (MSB0010718C) Clinical Studies
Enrollment Status: Active_not_recruiting
Publish Date: March 31, 2026
Intervention Type: Drug
Study Drug: Avelumab
Study Phase: Phase 3
A Phase Ib Open-Label, Dose-Finding Trial to Evaluate the Safety, Tolerability, and Pharmacokinetics of Avelumab in Combination With M9241(NHS-IL12) in Subjects With Locally Advanced, Unresectable, or Metastatic Solid Tumors
A Phase Ib Open-Label, Dose-Finding Trial to Evaluate the Safety, Tolerability, and Pharmacokinetics of Avelumab in Combination With M9241(NHS-IL12) in Subjects With Locally Advanced, Unresectable, or Metastatic Solid Tumors
Enrollment Status: Terminated
Publish Date: September 20, 2024
Intervention Type: Drug
Study Phase: Phase 1
A Phase III Clinical Trial Evaluating TheraSphere® in Patients With Metastatic Colorectal Carcinoma of the Liver Who Have Failed First Line Chemotherapy
A Phase III Clinical Trial Evaluating TheraSphere® in Patients With Metastatic Colorectal Carcinoma of the Liver Who Have Failed First Line Chemotherapy
Enrollment Status: Completed
Publish Date: March 29, 2022
Intervention Type: Device
Study Phase: Not Applicable
A Double-Blinded, Placebo-Controlled, Randomized Phase II Study of Enzalutamide With or Without the PI3 Kinase/mTOR Inhibitor LY3023414 in Men With Metastatic Castration Resistant Prostate Cancer
A Double-Blinded, Placebo-Controlled, Randomized Phase II Study of Enzalutamide With or Without the PI3 Kinase/mTOR Inhibitor LY3023414 in Men With Metastatic Castration Resistant Prostate Cancer
Enrollment Status: Completed
Publish Date: May 11, 2021
Intervention Type: Drug
Study Phase: Phase 2
A Phase 1/2a Multicenter, Open-Label, Dose-Escalation, Combination Study of RM-1929 and Photoimmunotherapy in Patients With Recurrent Head and Neck Cancer, Who in the Opinion of Their Physician, Cannot Be Satisfactorily Treated With Surgery, Radiation or Platinum Chemotherapy
A Phase 1/2a Multicenter, Open-Label, Dose-Escalation, Combination Study of RM-1929 and Photoimmunotherapy in Patients With Recurrent Head and Neck Cancer, Who in the Opinion of Their Physician, Cannot Be Satisfactorily Treated With Surgery, Radiation or Platinum Chemotherapy
Enrollment Status: Completed
Publish Date: February 26, 2020
Intervention Type: Combination product
Study Phase: Phase 1/Phase 2
View 4 Less Clinical Trials

12 Total Publications

Inflammation and mutational burden differentially associated with nivolumab or ipilimumab combination efficacy in colorectal cancer.
Inflammation and mutational burden differentially associated with nivolumab or ipilimumab combination efficacy in colorectal cancer.
Journal: Nature communications
Published: February 28, 2025
Similar Doctors
Expertise in
9
conditions
Dr. Kristine Ensrud
Internal Medicine
Expertise in
9
conditions
Dr. Kristine Ensrud
Internal Medicine

Minneapolis Veterans Administration Hospital

1 Veterans Dr, 
Minneapolis, MN 
 (4.6 miles away)
612-725-2158
Languages Spoken:
English
See accepted insurances

Kristine Ensrud is a primary care provider, practicing in Internal Medicine in Minneapolis, Minnesota. Dr. Ensrud is highly rated in 9 conditions, according to our data. Her clinical expertise encompasses Osteoporosis, Postmenopausal Osteoporosis, Menopause, Hormone Replacement Therapy (HRT), and Hip Replacement.

Expertise in
14
conditions
Dr. Nedaa Skeik
Internal Medicine
Expertise in
14
conditions
Dr. Nedaa Skeik
Internal Medicine

Allina Health Minneapolis Heart Institute-Centennial Lakes (Edina)

7373 France Ave S Ste 300, 
Edina, MN 
 (6.8 miles away)
612-863-6800
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Nedaa Skeik is an Internal Medicine provider practicing medicine in Edina, Minnesota. Dr. Skeik is highly rated in 14 conditions, according to our data. His clinical expertise encompasses Venous Insufficiency, Varicose Veins, Stasis Dermatitis and Ulcers, Tissue Biopsy, and Thrombectomy.

Expertise in
15
conditions
Dr. Thomas Meyer
Internal Medicine
Expertise in
15
conditions
Dr. Thomas Meyer
Internal Medicine

Mayo Clinic Health System In Red Wing

701 Hewitt Blvd, 
Red Wing, MN 
 (43.5 miles away)
651-267-5500
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Thomas Meyer is a primary care provider, practicing in Internal Medicine in Red Wing, Minnesota. Dr. Meyer is highly rated in 15 conditions, according to our data. His clinical expertise encompasses Primary Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), Lung Metastases, Chronic Cough, and Gastrostomy.

Frequently Asked Questions about Dr. Samith Kochuparambil

How do I make an appointment with Dr. Samith Kochuparambil?

You can book an appointment with Dr. Samith Kochuparambil by calling their office at 612-884-6300. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Samith Kochuparambil a top-rated expert for Multiple Myeloma?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Samith Kochuparambil is classified as an Distinguished expert for Multiple Myeloma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Samith Kochuparambil specialize in?

While Dr. Samith Kochuparambil is a Internal Medicine, they have specific expertise in Multiple Myeloma, Neuroendocrine Tumor, and Non-Muscle Invasive Bladder Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Internal Medicine.

Does Dr. Samith Kochuparambil participate in research or clinical trials?

Yes. Dr. Samith Kochuparambil has published 12 articles and abstracts on conditions like Multiple Myeloma. You can view a list of Dr. Samith Kochuparambil's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Samith Kochuparambil accept my insurance?

Dr. Samith Kochuparambil accepts most major insurance plans, including Aetna and Blue Cross Blue Shield. We recommend calling the office directly at 612-884-6300 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Kochuparambil's expertise for a condition
ConditionClose
    View All 47 Advanced Conditions
    View All 150 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile